Inspiring Excellence, Advancing Orthopaedics – The 55th Malaysian Orthopaedic Association Annual Scientific Meeting (MOA ASM 2026)
From 25th to 27th June 2026, the 55th Malaysian Orthopaedic Association Annual Scientific Meeting (MOA ASM 2026) unfolded at the Setia SPICE Convention Centre in Penang. Global Rep was honoured to be part of this inspiring gathering of orthopaedic professionals, researchers, medical device manufacturers and industry innovators. Centred on the theme “AI in Orthopaedics: Precision, Prediction, and Patient-Centered Care,” the meeting explored how technological innovation and clinical expertise can work together to advance orthopaedic practice and improve patient outcomes. The programme featured scientific sessions, professional exchanges and discussions on emerging developments in orthopaedic care. The atmosphere was charged with energy as the meeting showcased innovative ideas, fostered collaborative exchanges, and highlighted transformative advancements in science, technology, and clinical practice. With impactful sessions and dynamic discussions, MOA ASM 2026 reaffirmed its role in shaping the future of orthopaedics and driving excellence in patient care. For Global Rep, the event was more than just participation — it was an opportunity to connect. Engaging with key local establishments, overseas orthopaedic device manufacturers, and orthopaedic surgeons enriched our understanding of the orthopaedic industry and its evolving needs. These conversations also opened doors to explore how Global Rep can add value through independent authorized representation of foreign medical device manufacturers, medical device registrations, registration maintenance, and post‑market surveillance management in this region, while further strengthening partnerships with our valued clients. Supporting Your Medical Device Market Access in Malaysia Whether you are an overseas manufacturer planning to enter the Malaysian market or a local establishment seeking regulatory and compliance support, Global Rep is ready to assist you throughout the medical device lifecycle. Contact our team to learn how we can support your medical device registration, authorised representation and post-market compliance needs in Malaysia.
Traceability in Focus: Ensuring Compliance and Audit Readiness
Implantable medical devices may remain in the human body for a patient’s lifetime. Because of this, establishments that supply such devices must maintain comprehensive records to ensure full traceability — from the healthcare facility that received and performed the implantation procedure to the patient who received the device. This practice is not only mandated by regulations; it also empowers establishments to carry out post-market surveillance effectively, including corrective actions such as recalls, corrections, field safety notices, reporting to authorities, and issue investigations. On 29 June 2026, the Malaysia Medical Device Authority (MDA) issued a formal notice to Conformity Assessment Bodies (CABs), reiterating the requirement under Subregulation 3(2) of the Medical Device (Duties and Obligations of Establishments) Regulations 2019 for traceability of implantable devices up to the patient level. The MDA Policy Division is currently reviewing this matter and will issue a reference document to clarify the requirement and specify the enforcement date. In the meantime, establishments must maintain traceability up to the healthcare facility level. Starting 20 April 2026, CABs are required to assess distribution records to evaluate the adequacy of each establishment’s traceability and tracking system, make the necessary considerations, and provide a definitive conclusion on compliance in their audit reports. To avoid obstacles in your upcoming QMS implementation, ISO 13485 certification, and GDPMD audit, you should begin reviewing your system now to confirm that provisions are in place to support compliance with Subregulation 3(2). In addition, assess your current execution to verify conformity with these requirements. Get Expert Support for Traceability Compliance This is where Global Rep can support you. Our experienced regulatory and compliance experts will help you identify gaps, strengthen your system, and ensure effective execution. With our guidance, you can approach your audit with confidence, knowing your compliance framework is robust, traceability is assured, and your organization is prepared for sustained success.
Medical Device Classification in Malaysia
For any establishment planning to market a medical device in Malaysia, one of the very first and most critical steps is understanding how classification works. Many organizations underestimate this stage, assuming it is just a technical formality. In reality, medical device classification is the foundation of the entire regulatory pathway set by the Medical Device Authority (MDA). Why does this matter? Because classification directly determines how complex the registration process will be, how much documentation is required, how long approval takes, and even the overall cost. A wrong classification doesn’t just slow you down — it can mean rejection, regulatory delays, or costly rework. What Is Medical Device Classification Medical device risk classification is the system used to categorize devices into classes based on their potential risk to patients and users. In Malaysia, devices are classified into Class A, B, C, and D, aligned with the ASEAN Medical Device Directive (AMDD). Each class dictates the regulatory pathway, documentation requirements, and the level of scrutiny applied by the MDA. Malaysia Medical Device Classification Rules Medical device classification in Malaysia is governed by the Medical Device Regulations 2012, enacted under the Medical Device Act 2012 (Act 737). These regulations set out the framework for categorizing devices according to risk, ensuring that each class follows the appropriate regulatory pathway, documentation requirements, and level of oversight by the MDA. Malaysia medical device classification rules: Key Factors That Determine Medical Device Classification An establishment intending to register a medical device shall obtain and fully comprehend the following information to ensure accurate classification of its products. Such information is typically documented in the product brochure, instructions for use or user manual, and labeling. Consultation with the manufacturer may also be undertaken when necessary. List Key Factors Examples 1 The duration of contact of the device with the body · Transient use – Surgical scalpel · Long term use – Orthopaedic implants 2 The degree of, and site of, invasiveness into the body · Non-invasive – Plaster · Invasive – Catheter 3 Whether the device deliver medicines or energy to the patient · Deliver medicine – Infusion pump · Deliver or exchange energy – Defibrillator 4 Whether the device is intended to have a biological effect on the body · Drug eluting-stent 5 Intended action on the human body · Therapeutic – Dialysis machine · Diagnostic – Blood pressure monitor · Supportive – Cardiopulmonary bypass machine 6 Local versus systemic effects · Local – Skin dressing · Systemic – Mechanical ventilator 7 Whether the device comes into contact with injured skin · Burn dressing 8 Whether for diagnosis or treatment · Diagnosis – Stethoscope · Treatment – Pacemaker 9 The ability to be re-used or not · Single use – Hypodermic needle · Reusable – Infrared thermometer 10 Combination of devices · Bone graft with antiseptic Once sufficient information has been gathered and properly understood, the establishment shall review the criteria set forth under the relevant classification rules in the Medical Device Regulation 2012 to determine the most appropriate medical device classification. Alternatively, the establishment may consult the MDA Public Search to review the classifications of registered medical devices. Why Proper Classification Is Important? An incorrect classification can derail your entire medical device registration process. It may cause rejection, regulatory delays, or significant additional costs. That’s why it pays to work with experts. Contact Global Rep and consult with our professionals. With years of proven experience, we can guide you in determining the correct classification and help you successfully navigate this critical step. For a deeper dive into what comes next after classification, refer to our blog: Malaysia Medical Device Regulatory Affairs: Overview of Regulatory Framework and Requirements — where we outline the subsequent steps in the registration pathway and compliance process. You may also refer to our blog: Navigating Malaysia’s Medical Device Registration Process, which highlights the key elements of Malaysia’s medical device registration framework, helping establishments prepare for documentation, timelines, regulatory expectations, and the necessary monetary investment.
Exploring Tomorrow’s Healthcare at CMEF Spring 2026, Shanghai
The China International Medical Equipment Fair (CMEF) Spring 2026 promises to be one of the most influential gatherings in the global medical device and healthcare technology industry. As Asia’s largest medical equipment exhibition, it brings together innovators, manufacturers, distributors, and healthcare professionals from around the world to showcase cutting-edge technologies, explore emerging trends, and build strategic partnerships. The 93rd China International Medical Equipment Fair (CMEF) Spring 2026 was held in Shanghai from April 9 to 12, 2026, at the National Exhibition and Convention Center. According to reports, the four-day event drew over 300,000 participants and focused on the theme “Innovation Fusion, Boundless Evolution,” showcasing the latest advancements in global medical device technology. This year’s event highlighted advancements in digital health, AI-driven diagnostics, and sustainable medical solutions — offering participants an unparalleled opportunity to connect, collaborate, and shape the future of healthcare. Global Rep is proud to have participated in such an influential event, and we are pleased to have achieved the objectives we set beforehand: Engaging with Our Valued Customers At CMEF Spring 2026, we had the privilege of meeting with our valued customers to discuss the latest regulatory updates, the status of local representation, and opportunities for collaboration with importers and distributors. These conversations also addressed upcoming plans in Malaysia and evolving customer expectations. During these meetings, we shared insights that added tangible value to our customers’ marketing strategies, while providing expertise on medical device registration and ongoing registration maintenance. Beyond Malaysia, we explored potential international collaborations, further strengthening our global network and expanding opportunities for future cooperation. Exploring Product Innovation and Technological Advancement The world’s most advanced innovations and technological breakthroughs converged at CMEF Spring 2026. Across the exhibition halls, we explored diverse product categories including Medical Imaging, IVD & Life Sciences, Medical Consumables, Device Manufacturing, Rehabilitation & Home Care, Operating Room & Surgical, Smart Health & AI, Medical Optics, Hospital Construction & Management, Sterilization & Infection Control, Emergency & Rescue, Medical Robotics, Simulation Medicine, Pet Health, and Medical Electronics. CMEF Spring 2026 was truly an eye-opening experience that deepened our understanding of the industry and facilitated valuable exchanges with exhibitors. These interactions enabled us to refine and optimize our strategies and future plans. We were also pleased to address numerous questions on medical device registration in Malaysia, providing clarity and guidance that added value to our customers and partners. In addition, we gathered product information and innovations directly relevant to our customers, equipping us to deliver insights that enhance their businesses and strengthen their market competitiveness. Looking ahead, we remain committed to growing together with our customers, fostering collaboration that drives shared success both in Malaysia and internationally. Flagship Continuation Building on the success of CMEF Spring 2026, the next flagship event — the 94th China International Medical Equipment Fair (CMEF Autumn 2026) — will be held from October 21–24, 2026 at the Capital International Exhibition & Convention Center (CIECC), Beijing. As a highly anticipated milestone in the global medical device calendar, CMEF Autumn 2026 will extend the momentum of the Spring edition, delivering fresh insights, fostering new partnerships, and unveiling transformative solutions that continue to shape the future of healthcare worldwide. We Never Forget Our Purpose Guided by Global Rep’s purpose, we are committed to empowering foreign medical device manufacturers, as well as local importers and distributors, in delivering safe and innovative solutions that help improve and restore quality of life. We remain steadfast in our mission. We will continue to explore new opportunities worldwide, ensuring that Global Rep stands not only as a trusted partner but also as a meaningful presence in the medical device industry. Through collaboration, innovation, and shared success, we strive to make a lasting impact on healthcare and the communities we serve. Connect With Us for Medical Device Regulatory Support Inspired by the latest innovations and global collaborations at CMEF Spring 2026, we continue to support medical device manufacturers, importers, and distributors in navigating regulatory requirements and expanding into the Malaysian market. Get in touch with us today to explore how we can support your medical device registration, compliance, and business growth.
Navigating Malaysia’s Medical Device Registration Process
Malaysia has a well‑established regulatory framework to ensure that medical devices placed on the market are safe, effective, and of high quality. Registration is not just a formality — it is the gateway to market access. Whether you are a manufacturer, authorized representative, importer, or distributor, compliance is mandatory. It directly impacts product approval, market entry, and patient safety. This guide explains the registration process in a clear, structured way so businesses can prepare for successful submission and approval. What Is Medical Device Registration in Malaysia? Medical device registration in Malaysia is an official process of evaluating and approving a medical device by the Medical Device Authority (MDA) before it can be legally sold or distributed in the country. Medical device registration ensures that a device is safe, effective, and compliant before it can be marketed. It protects patients, builds trust with regulators, and confirms that the product meets recognized standards of quality and performance. In Malaysia, medical device registration is the responsibility of the local manufacturer or the local authorized representative appointed by a foreign manufacturer. Regulatory Authority in Malaysia The governing body responsible for medical device regulation is the MDA. It is a statutory body under the Ministry of Health Malaysia, responsible for regulating medical devices for human use, ensuring their safety, quality, and performance throughout their lifecycle. Its core roles include registration, licensing, conformity assessment oversight, post‑market surveillance, and enforcement. The MDA operates under the Medical Device Act 2012 (Act 737) and Medical Device Authority Act 2012 (Act 738), which are key components of Malaysia medical device regulations. Classification of Medical Devices Malaysia adopts a risk based classification system to classify medical devices according to the level of potential risk they pose to patients and users. This classification directly affects the medical device registration process, including documentation requirements, evaluation depth, approval timeline and registration cost. The following is a simplified reference table illustrating examples for each device class: Class Risk Level Device Examples A Low Risk Surgical retractors / Tongue depressors B Low-moderate Risk Hypodermic needle / Suction equipment C Moderate-high Risk Lung ventilator / Orthopaedic implants D High Risk Heart valves / Implantable defibrillator Understanding the correct classification is a critical step in Malaysia medical device registration, as misclassification can lead to delays, rejection, or compliance issues. In medical device registrations, classification is often one of the first and most important decisions before starting the registration process. Key Requirements for Medical Device Registration in Malaysia Successfully completing Malaysia medical device registration requires more than just submitting an application. Companies must meet several regulatory conditions under Malaysia medical device regulations that ensure accountability, traceability, and product safety throughout the device lifecycle. 1. Business Registration and Local Establishment In Malaysia, medical device registration is the responsibility of local manufacturers and the authorized representatives appointed by foreign manufacturers. Both entities must be legitimate legal entities registered with the Companies Commission of Malaysia (SSM), and licensed by the MDA, thereby ensuring that a responsible party is in place to manage regulatory compliance, product distribution, and post‑market obligations. 2. Authorized Representative (AR) An authorized representative for medical devices acts as the link between the foreign manufacturer and MDA. The AR manages medical device registrations, maintains records, and supports post market activities like adverse event reporting. 3. Conformity Assessment Conformity assessment is carried out by Conformity Assessment Bodies (CABs) licensed by the MDA to evaluate the safety, efficacy, and regulatory compliance of medical devices. Class A devices are exempt from this requirement, whereas Class B, C, and D devices must undergo conformity assessment before submission to the MDA for registration evaluation. 4. Technical Documentation The Malaysia Medical Device Regulation 2012 specifies the technical documentation requirements that form the Common Submission Dossier Template (CSDT). Local manufacturers and authorized representatives of foreign manufacturers are required to prepare a complete and adequate CSDT in order to undergo conformity assessment by a licensed CAB and subsequent application evaluation by the MDA. A complete and adequate CSDT must fully demonstrate the safety, efficacy, and regulatory compliance of the medical devices. 5. Compliance Standards Medical devices shall be designed, validated, and manufactured in accordance with the state of the art of the industry. The state of the art is established and documented through recognized standards. Compliance with these standards demonstrates the safety, efficacy, and regulatory conformity of the device. 6. Medical Device Registration Medical Device Act 2012 (Act 737) mandates that medical devices shall be registered with the MDA before it can be marketed in Malaysia. Marketing unregistered medical devices in Malaysia is a serious offence under the said act. Companies or individuals found guilty face fines up to RM200,000, imprisonment up to 3 years, or both. Devices may also be seized, and establishments risk suspension or revocation of their MDA licence. More information: Medical Device Regulatory Affairs: Overview of Regulatory Framework and Requirements 4-Parties-4-Activities Model The medical device registration process in Malaysia involves 4 key parties, each with vital responsibilities. Their roles and activities are summarized below: Share documents Review & prepare dossier Conformity assessment – Verification* Conformity assessment – Full* Registration Evaluation Manufacturer 1 Global Rep 2 CAB 3a 3b MDA 4 Note:* Not applicable to Class A device3a if the device has obtained a Malaysia MDA‑recognized pre‑market approval.3b if the device has not obtained any Malaysia MDA recognized pre-market approval. Malaysia Medical Device Registration Cost The cost of medical device registration in Malaysia comprises the conformity assessment fees charged by licensed CABs for Class B, C & D devices, and the registration fees payable to the MDA. Establishments may also need to allocate a budget for professional service fees if external consultants or local authorized representatives are engaged. In general, registration fees for the MDA are charged in two stages: application stage and registration stage. The application fee is paid when submitting the dossier to MDA, while the registration fee is paid after evaluation and approval. The amount depends on the device classification. Device Class Application Fee (RM) Registration Fee, (RM) Class A 500
Participate in Malaysia-Thailand Medical Device Regulatory Reliance Program
Are you planning to expand your medical device registration across ASEAN while reducing regulatory complexity and approval timelines? The Malaysia-Thailand Medical Device Regulatory Reliance Program offers a streamlined pathway designed to make cross-border registration faster, more efficient, and more accessible for medical device companies. For medical device manufacturers, distributors, and authorized representatives, understanding this program can help reduce uncertainty and create a clearer pathway when entering the Malaysian and Thai medical device markets. Why Does This Matter to You? According to Data Bridge Market Research, Malaysia’s medical device market was valued at USD 63.78 billion in 2024 and is projected to reach USD 112.62 billion by 2032, reflecting a compound annual growth rate (CAGR) of 7.50%. Based on the same source, Thailand’s medical device market was valued at USD 124.35 billion in 2024 and is expected to reach USD 237.97 billion by 2032, with a CAGR of 9.21%. With these positive growth rates, the Malaysia–Thailand medical device markets are expected to expand steadily. This means your medical devices have a growing stage to perform on. In 2024, their combined market represented approximately 8% of the Asia Pacific (APAC) medical device market, and by 2032 it is projected to account for about 7%, underscoring the continued significance of Malaysia and Thailand within the APAC region. Milestones That Shape Your Path On 4 December 2025, the Medical Device Authority (MDA) of Malaysia and the Thai Food and Drug Administration (Thai FDA) signed a Confidentiality Agreement to strengthen regulatory cooperation and officially launched a three‑month pilot of the Medical Device Regulatory Reliance Program (1 February to 30 April 2026) under the agreement. The signing took place during the 29th GHWP Annual Meeting in Bangkok, marking a significant step toward enhanced regulatory reliance between the two countries. On 1 May 2026, both authorities jointly announced the successful completion of the pilot program and the immediate full implementation of the MDA–Thai FDA Medical Device Regulatory Reliance Program for the registration of Class B, C, and D medical devices in Malaysia and Thailand. These milestones aren’t just history—they’re the foundation for your smoother market entry. What You Gain The Malaysia–Thailand Medical Device Regulatory Reliance Program aims to streamline medical device registration by allowing both countries to rely on each other’s regulatory reviews, reducing duplication, accelerating approvals, and improving patient access to safe, high‑quality devices. Under the Malaysia-Thailand Medical Device Regulatory Reliance Program, medical devices already registered with the Thai FDA may be registered in Malaysia through the Verification pathway, which involves a Conformity Assessment by verification rather than the more extensive Full Conformity Assessment process. Conversely, medical devices registered with the Malaysia MDA can benefit from a simplified pathway in Thailand, as they are not required to undergo external expert review when applying for registration with the Thai FDA. To further support this regulatory framework, the Thai FDA is also developing a policy titled “List of Reference Agencies Recognized by the Thai Food and Drug Administration for Inspection or Certification of Medical Devices or Medical Device Establishments”, which will strengthen mutual recognition and facilitate smoother cross-border registration between both countries. In short: less duplication, faster approvals, and earlier patient access. Unlock Medical Device Market Access in Thailand and Malaysia Global Rep was honored to participate in the pilot program by registering MDA-approved devices with the Thai FDA. The process has been progressing smoothly and is expected to conclude soon. Because we’ve already navigated this pathway, we are well-positioned to help you register your medical devices in Thailand efficiently and without unnecessary hurdles. Likewise, we are ready to support medical device registration in our home country, Malaysia. The question is no longer if you should participate—it’s when. With the Malaysia-Thailand Medical Device Regulatory Reliance Program now fully implemented, the opportunity is already here. Are you ready to take the next step with Global Rep? Contact our team today to discuss your medical device registration strategy and discover how we can help streamline your medical device market access in Thailand and Malaysia with confidence.